93025-71-9 Usage
Description
Cyclohexaneacetic acid,α-[(phenylmethoxy)carbonyl]amino]-, also known as 2-(((Benzyloxy)carbonyl)amino)-2-cyclohexylacetic Acid, is a chemical compound derived from 2-Amino-2-cyclohexylacetic Acid (5664-29-9), which serves as an important building block in the synthesis of various pharmaceuticals and chemical products.
Uses
Used in Pharmaceutical Industry:
Cyclohexaneacetic acid,α-[(phenylmethoxy)carbonyl]amino]is used as an intermediate in the synthesis of various pharmaceuticals and drug candidates. Its unique structure allows for the development of new compounds with potential therapeutic applications.
Used in Chemical Synthesis:
Cyclohexaneacetic acid,α-[(phenylmethoxy)carbonyl]amino]is used as a key building block in the synthesis of various chemical products, including specialty chemicals, agrochemicals, and other industrial applications. Its versatility in chemical reactions makes it a valuable component in the development of new materials and compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 93025-71-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,0,2 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 93025-71:
(7*9)+(6*3)+(5*0)+(4*2)+(3*5)+(2*7)+(1*1)=119
119 % 10 = 9
So 93025-71-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H21NO4/c18-15(19)14(13-9-5-2-6-10-13)17-16(20)21-11-12-7-3-1-4-8-12/h1,3-4,7-8,13-14H,2,5-6,9-11H2,(H,17,20)(H,18,19)
93025-71-9Relevant articles and documents
Asymmetric hydrogenation of N-sulfonylated-α-dehydroamino acids: Toward the synthesis of an anthrax lethal factor inhibitor
Shultz, C. Scott,Dreher, Spencer D.,Ikemoto, Norihiro,Williams, J. Michael,Grabowski, Edward J. J.,Krska, Shane W.,Sun, Yongkui,Dormer, Peter G.,DiMichele, Lisa
, p. 3405 - 3408 (2007/10/03)
(Chemical Equation Presented) A novel and highly enantioselective Ru-catalyzed hydrogenation of N-sulfonylated-α-dehydroamino acids has been discovered and demonstrated in the synthesis of an anthrax lethal factor inhibitor (LFI). Herein, this methodology is used to prepare N-sulfonylated amino acids in up to 98% ee. This unprecedented hydrogenation uses a chiral Ru catalyst rather than Rh as typical for acylated dehydroamino acids and esters, and this work reports the first asymmetric hydrogenation of a tetrasubstituted dehydroamino acid derivative using a Ru catalyst.
